Author/Creator: Boumber, Yanis - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Boumber, Yanis

1. Biomarkers for immune checkpoint inhibition in non–small cell lung cancer (NSCLC). Issue 2 (6th November 2019)

Authors:: Bodor, J. Nicholas; Boumber, Yanis; Borghaei, Hossein
Journal:: Cancer
Issue:: Volume 126:Issue 2(2020)
Page Start:: 260
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. INST OX‐05‐024: first line gemcitabine, oxaliplatin, and erlotinib for primary hepatocellular carcinoma and bile duct cancers: a multicenter Phase II trial. (11th August 2017)

Authors:: Patt, Yehuda Z.; Murad, Waheed; Fekrazad, Mohammed H.; Baron, Ari D.; Bansal, Pranshu; Boumber, Yanis; Steinberg, Kim; Lee, Sang‐Joon; Bedrick, Ed; Du, Ruofei; Lee, Fa Chyi
Journal:: Cancer medicine
Issue:: Volume 6:Number 9(2017:Sep.)
Page Start:: 2042
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Sequential occurrence of small cell and non-small lung cancer in a male patient: Is it a transformation?. Issue 12 (2nd December 2017)

Authors:: Wahab, Ahsan; Kesari, Kavitha; Chaudhary, Siddique; Khan, Mahin; Khan, Hafiz; Smith, Susan; Boumber, Yanis
Journal:: Cancer biology & therapy
Issue:: Volume 18:Issue 12(2017)
Page Start:: 940
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. The role of local ablative therapy in oligometastatic non-small-cell lung cancer: hype or hope. (December 2016)

Authors:: Bansal, Pranshu; Rusthoven, Chad; Boumber, Yanis; Gan, Gregory N
Journal:: Future oncology
Issue:: Volume 12:Number 23(2016)
Page Start:: 2713
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗